Skip to main content
. 2021 May;67:101311. doi: 10.1016/j.arr.2021.101311

Table 4.

Summary: Open questions in the field.

Research question Figure
1 Does regional vulnerability to normal ageing determine region-specific susceptibility in neurodegenerative disease? 1
2 Do mechanisms of ageing at the nervous system tissue, cellular and molecular level determine regional vulnerability to both normal ageing and neurodegenerative disease? 2
3 Can differential ageing conceptually extend across scales, from the individual to subcellular level? 3
4 Are the initial sites affected by neurodegenerative pathology also those that are most prone to ageing?
5 Can the concept of regional susceptibility to ageing be extended across other age-related diseases, such as cardiovascular disease?
6 Is it experimentally tractable to directly compare the ageing status of single cells, cellular subregions, or individual organelles within cells?
7 How can an understanding of region-specific vulnerability to ageing and disease be used to guide therapeutic advance e.g. ASO delivery, cellular implantation?